These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 20521644

  • 1. A heterologous neuraminidase subtype strategy for the differentiation of infected and vaccinated animals (DIVA) for avian influenza virus using an alternative neuraminidase inhibition test.
    Avellaneda G, Sylte MJ, Lee CW, Suarez DL.
    Avian Dis; 2010 Mar; 54(1 Suppl):272-7. PubMed ID: 20521644
    [Abstract] [Full Text] [Related]

  • 2. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ, Lee CW, Sylte M, Suarez DL.
    Vaccine; 2009 Oct 19; 27(44):6247-60. PubMed ID: 19686695
    [Abstract] [Full Text] [Related]

  • 3. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.
    Lee CW, Senne DA, Suarez DL.
    Vaccine; 2004 Aug 13; 22(23-24):3175-81. PubMed ID: 15297071
    [Abstract] [Full Text] [Related]

  • 4. Differentiation of infected and vaccinated animals (DIVA) using the NS1 protein of avian influenza virus.
    Avellaneda G, Mundt E, Lee CW, Jadhao S, Suarez DL.
    Avian Dis; 2010 Mar 13; 54(1 Suppl):278-86. PubMed ID: 20521645
    [Abstract] [Full Text] [Related]

  • 5. Overview of avian influenza DIVA test strategies.
    Suarez DL.
    Biologicals; 2005 Dec 13; 33(4):221-6. PubMed ID: 16257543
    [Abstract] [Full Text] [Related]

  • 6. Development and evaluation of an avian influenza, neuraminidase subtype 1, indirect enzyme-linked immunosorbent assay for poultry using the differentiation of infected from vaccinated animals control strategy.
    Liu Y, Mundt E, Mundt A, Sylte M, Suarez DL, Swayne DE, García M.
    Avian Dis; 2010 Mar 13; 54(1 Suppl):613-21. PubMed ID: 20521703
    [Abstract] [Full Text] [Related]

  • 7. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
    Sylte MJ, Hubby B, Suarez DL.
    Vaccine; 2007 May 10; 25(19):3763-72. PubMed ID: 17350145
    [Abstract] [Full Text] [Related]

  • 8. New DIVA vaccine for the protection of poultry against H5 highly pathogenic avian influenza viruses irrespective of the N-subtype.
    Peeters B, de Boer SM, Tjeerdsma G, Moormann R, Koch G.
    Vaccine; 2012 Nov 19; 30(49):7078-83. PubMed ID: 23036502
    [Abstract] [Full Text] [Related]

  • 9. Effects of homologous and heterologous neuraminidase vaccines in chickens against H5N1 highly pathogenic avian influenza.
    Lee YJ, Sung HW, Choi JG, Lee EK, Jeong OM, Kwon YK, Kwon JH, Song CS, Kimd JH.
    Avian Dis; 2007 Mar 19; 51(1 Suppl):476-8. PubMed ID: 17494612
    [Abstract] [Full Text] [Related]

  • 10. Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza.
    Capua I, Terregino C, Cattoli G, Mutinelli F, Rodriguez JF.
    Avian Pathol; 2003 Feb 19; 32(1):47-55. PubMed ID: 12745380
    [Abstract] [Full Text] [Related]

  • 11. Novel use of a N2-specific enzyme-linked immunosorbent assay for differentiation of infected from vaccinated animals (DIVA)-based identification of avian influenza.
    Kwon JS, Kim MC, Jeong OM, Kang HM, Song CS, Kwon JH, Lee YJ.
    Vaccine; 2009 May 21; 27(24):3189-94. PubMed ID: 19446190
    [Abstract] [Full Text] [Related]

  • 12. Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals.
    Swayne DE, Avellaneda G, Mickle TR, Pritchard N, Cruz J, Bublot M.
    Avian Dis; 2007 Sep 21; 51(3):697-704. PubMed ID: 17992929
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A genetically engineered H5 protein expressed in insect cells confers protection against different clades of H5N1 highly pathogenic avian influenza viruses in chickens.
    Oliveira Cavalcanti M, Vaughn E, Capua I, Cattoli G, Terregino C, Harder T, Grund C, Vega C, Robles F, Franco J, Darji A, Arafa AS, Mundt E.
    Avian Pathol; 2017 Apr 21; 46(2):224-233. PubMed ID: 27807985
    [Abstract] [Full Text] [Related]

  • 15. DIVA--a vaccination strategy enabling the detection of field exposure to avian influenza.
    Capua I, Cattoli G, Marangon S.
    Dev Biol (Basel); 2004 Apr 21; 119():229-33. PubMed ID: 15742633
    [Abstract] [Full Text] [Related]

  • 16. Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy.
    Park JK, Lee DH, Youn HN, Kim MS, Lee YN, Yuk SS, Lim TH, Jang JH, Kwon JH, Kim BY, Kang SM, Seong BL, Lee JB, Park SY, Choi IS, Song CS.
    Influenza Other Respir Viruses; 2013 May 21; 7(3):340-8. PubMed ID: 22716302
    [Abstract] [Full Text] [Related]

  • 17. Development and validation of an anti-N3 indirect immunofluorescent antibody test to be used as a companion diagnostic test in the framework of a "DIVA" vaccination strategy for avian influenza infections in poultry.
    Cattoli G, Milani A, Bettini F, Serena Beato M, Mancin M, Terregino C, Capua I.
    Avian Pathol; 2006 Apr 21; 35(2):154-9. PubMed ID: 16595309
    [Abstract] [Full Text] [Related]

  • 18. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.
    Vaccine; 2009 Jan 29; 27(5):773-85. PubMed ID: 19041677
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus.
    Swayne DE, Beck JR, Mickle TR.
    Avian Dis; 1997 Jan 29; 41(4):910-22. PubMed ID: 9454926
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.